1. A1.12 Endogenous SLPI released by rheumatoid synovial fibroblasts control BAFF-dependent-B cell activation in vitro and in the CIA and RA/SCID-arthritis models. (31st January 2014) Authors: Kam, N W; Brentano, F; Kyburz, D; Gay, S; Filer, A; Buckley, C; Pitzalis, C; Bombardieri, M Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 1(2014) Page Start: A5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis. Issue 1 (14th February 2008) Authors: Brentano, F; Ospelt, C; Stanczyk, J; Gay, R E; Gay, S; Kyburz, D Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 1(2009) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Calcium pyrophosphate deposition disease: a frequent finding in patients with long-standing erosive gout. (4th March 2018) Authors: Ankli, B; Kyburz, D; Hirschmann, A; Hügle, T; Manigold, T; Berger, CT; Daikeler, T Journal: Scandinavian journal of rheumatology Issue: Volume 47:Number 2(2018) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland. Issue 1 (7th May 2020) Authors: Finckh, A; Tellenbach, C; Herzog, L; Scherer, A; Moeller, B; Ciurea, A; von Muehlenen, I; Gabay, C; Kyburz, D; Brulhart, L; Müller, R; Hasler, P; Zufferey, P Journal: RMD open Issue: Volume 6:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor α agents: an open-label observational study. Issue 9 (15th March 2006) Authors: Brulhart, L; Ciurea, A; Finckh, A; Notter, A; Waldburger, J M; Kyburz, D; Gabay, C Journal: Annals of the rheumatic diseases Issue: Volume 65:Issue 9(2006) Page Start: 1255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P070/O09 miR-221-3p is upregulated in rheumatoid arthritis and affects JAK3/STAT3 signaling in M2-macrophages. (March 2019) Authors: Quero, L; Hanser, E; Tiaden, AN; Kyburz, D Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0174 Drug retention of tofacitinib versus biologic antirheumatic agents in rheumatoid arthritis: observational data from the swiss scqm registry. (15th June 2017) Authors: Finckh, A; Herzog, L; Scherer, A; Dudler, J; Moeller, B; Ciurea, A; Mueller, R; Hasler, P; Exer, P; Muehlenen, I von; Kyburz, D; Gabay, C; Zufferey, P Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Toll-like receptors in rheumatoid arthritis joint destruction mediated by two distinct pathways. (12th October 2004) Authors: Ospelt, C; Kyburz, D; Pierer, M; Seibl, R; Kurowska, M; Distler, O; Neidhart, M; Muller-Ladner, U; Pap, T; Gay, R E; Gay, S Journal: Annals of the rheumatic diseases Issue: Volume 63(2004)Supplement 2 Page Start: ii90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA). Issue 9 (2nd September 2008) Authors: Roelofs, M F; Wenink, M H; Brentano, F; Abdollahi-Roodsaz, S; Oppers-Walgreen, B; Barrera, P; van Riel, P L C M; Joosten, L A B; Kyburz, D; van den Berg, W B; Radstake, T R D J Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 9(2009) Page Start: 1486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development. (22nd February 2011) Authors: Broen, J C A; Gourh, P; Vonk, M C; Beretta, L; Niederer, F; Rueda, B; Geurts-van Bon, L; Brouwer, C; Hesselstrand, R; Herrick, A; Worthington, J; Hunzelman, N; Fonseca, Denton C; Riemekasten, G; Kiener, H; Scorza, R; Simeon, C P; Fonollosa, V; Carreira, P; Ortego-Centeno, N Journal: Annals of the rheumatic diseases Issue: Volume 70(2011)Supplement 2 Page Start: A19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗